Are Women More at Risk of False-Positive Primary Aldosteronism Screening and Unnecessary Suppression Testing than Men?
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Because primary aldosteronism is not uncommon, specifically treatable and in some cases curable, and carries higher risks for cardiovascular morbidity and mortality than essential hypertension, screening hypertensive patients for its presence by measuring aldosterone to renin ratio (ARR) is increasingly common. A significantly higher false-positive ARR rate for women than men, resulting in unnecessary suppression tests has previously been reported. METHODS: Using a new, highly accurate aldosterone assay and both of the currently widely used renin assays, ARR was measured in 19 normal, ovulating women at three time points in the menstrual cycle and compared with single measurements in 21 normal males of similar age. RESULTS: ARRs in males were possibly too well down in the current normal range. Although normotensive and normokalemic, two women had raised ARRs in the luteal phase but only when direct renin concentration (DRC) was used. Their DRC levels were low at all sampling times [despite midrange plasma renin activity levels], whereas their progesterone and aldosterone levels were highest for the group. Saline suppression testing, performed in one of them, showed normal aldosterone suppressibility. CONCLUSION: False-positive ARRs in normal women during the luteal phase only when DRC is used may explain the higher incidence of false-positive ARRs in hypertensive women than men and suggest the following: 1) plasma renin activity is preferable to DRC in determination of ARR and 2) new reference ranges for ARR that take into account gender and sex hormone levels are required.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Funder, J. W., Carey, R. M., Fardella, C., Gomez-Sanchez, C. E., Mantero, F., Stowasser, M., Young, W. F., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0104 · Cited by 1,554
Self-citationA prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients
Rossi, G. P., Bernini, G., Caliumi, C., Desideri, G., Fabris, B., Ferri, C., Ganzaroli, C., Giacchetti, G., Letizia, C., Maccario, M., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.059 · Cited by 1,467
Primary aldosteronism: renaissance of a syndrome
Young, W. F. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02775.x · Cited by 680
HIGH INCIDENCE OF PRIMARY ALDOSTERONISM IN 199 PATIENTS REFERRED WITH HYPERTENSION
Gordon, R. D., Stowasser, M., Tunny, T. J., Klemm, S. A., & Rutherford, J. C. (1994) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1994.tb02519.x · Cited by 496
Self-citationDrug Effects on Aldosterone/Plasma Renin Activity Ratio in Primary Aldosteronism
Mulatero, P., Rabbia, F., Milan, A., Paglieri, C., Morello, F., Chiandussi, L., & Veglio, F. (2002) · Hypertension · doi:10.1161/01.hyp.0000038478.59760.41 · Cited by 392
Renin angiotensin system and gender differences in the cardiovascular system
Fischer, M. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00479-5 · Cited by 384
Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure
Oelkers, W. K. H. (1996) · Steroids · doi:10.1016/0039-128x(96)00007-4 · Cited by 333
Guo, T., Taylor, R. L., Singh, R. J., & Soldin, S. J. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.03.034 · Cited by 227
Vogeser, M., & Parhofer, K. (2007) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2007-981458 · Cited by 176
Conception and pharmacodynamic profile of drospirenone
Elger, W. A. G., Beier, S., Pollow, K., Garfield, R. E., Shi, S. Q., & Hillisch, A. (2003) · Steroids · doi:10.1016/j.steroids.2003.08.008 · Cited by 157
Schirpenbach, C., Seiler, L., Maser-Gluth, C., Beuschlein, F., Reincke, M., & Bidlingmaier, M. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2006.068502 · Cited by 146
Qureshi, A. C., Bahri, A., Breen, L. A., Barnes, S. C., Powrie, J. K., Thomas, S. M., & Carroll, P. V. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02784.x · Cited by 133
Primary aldosteronism: A common and curable form of hypertension.
Young, W. F. (1999) · PubMed · Cited by 121
Primary aldosteronism: an update on screening, diagnosis and treatment
Rossi, G. P., Pessina, A. C., & Heagerty, A. M. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282f4b3e6 · Cited by 120
Measurement of Aldosterone in Human Plasma by Semiautomated HPLC–Tandem Mass Spectrometry
Taylor, P. J., Cooper, D. P., Gordon, R. D., & Stowasser, M. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.116004 · Cited by 118
Self-citationRelationship between Aldosterone and Progesterone in the Human Menstrual Cycle
Szmuilowicz, E. D., Adler, G. K., Williams, J. S., Green, D. E., Yao, T. M., Hopkins, P. N., & Seely, E. W. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1154 · Cited by 107
Regulation of angiotensinogen gene expression by estrogen
Gordon, M. S., Chin, W. W., & Shupnik, M. A. (1992) · Journal of Hypertension · doi:10.1097/00004872-199204000-00007 · Cited by 106
Determination of aldosterone in serum by liquid chromatography–tandem mass spectrometry
Turpeinen, U., Hämäläinen, E. K., & Stenman, U. (2007) · Journal of Chromatography B · doi:10.1016/j.jchromb.2007.11.005 · Cited by 88
The challenge of more robust and reproducible methodology in screening for primary aldosteronism
Gordon, R. D. (2004) · Journal of Hypertension · doi:10.1097/00004872-200402000-00006 · Cited by 70
Self-citationAldosterone Secretory Rates in the Normal Menstrual Cycle
GRAY, M. J., STRAUSFELD, K. S., WATANABE, M., SIMS, E. A. H., & SOLOMON, S. (1968) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-28-9-1269 · Cited by 67
Plasma Aldosterone and Renin Activity during the Menstrual Cycle1
KATZ, F. H., & ROMFH, P. (1972) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-34-5-819 · Cited by 65
Elliott, W. J. (2009) · Yearbook of Cardiology · doi:10.1016/s0145-4145(08)79419-x · Cited by 62
Pizzolo, F., Raffaelli, R., Memmo, A., Chiecchi, L., Pavan, C., Guarini, P., Guidi, G. C., Franchi, M., Corrocher, R., & Olivieri, O. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e32833266e3 · Cited by 54
Hannemann, A., Friedrich, N., Lüdemann, J., Völzke, H., Rettig, R., Peters, J., Reincke, M., Döring, A., Nauck, M. A., & Wallaschofski, H. (2010) · Hormone and Metabolic Research · doi:10.1055/s-0030-1247545 · Cited by 49
Fommei, E., Ghione, S., Ripoli, A., Maffei, S., Cecco, P. D., Iervasi, A., & Turchi, S. (2008) · Journal of Human Hypertension · doi:10.1038/jhh.2008.109 · Cited by 45
Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism
MULATERO, P. (2003) · American Journal of Hypertension · doi:10.1016/s0895-7061(03)00766-0 · Cited by 41
The Aldosterone???Renin Ratio in Screening for Primary Aldosteronism
Stowasser, M., & Gordon, R. D. (2004) · The Endocrinologist · doi:10.1097/01.ten.0000139006.29471.9e · Cited by 41
Self-citationPrimary aldosteronism: an update on screening, diagnosis and treatment
Kaplan, N. M. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e328302ee10 · Cited by 13
ALDOSTERONE SECRETORY RATES IN THE NORMAL MENSTRUAL CYCLE
Gray, M. J., STRAUSFELD, K. S., Watanabe, M., et al. (1969) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-196906000-00023 · Cited by 3
Cited by
Diagnosis and treatment of primary aldosteronism: practical clinical perspectives
Young, W. F. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12831 · Cited by 325
Stowasser, M., & Gordon, R. D. (2016) · Physiological Reviews · doi:10.1152/physrev.00026.2015 · Cited by 159
“We reported luteal concentrations of plasma aldosterone, DRC, and PRA to be higher than follicular in 19 healthy, normotensive females (12).”
BackgroundSelf-citationRossi, G. P., Bisogni, V., Bacca, A., Belfiore, A., Cesari, M., Concistrè, A., Pinto, R. D., Fabris, B., Fallo, F., Fava, C., et al. (2020) · International Journal of Cardiology Hypertension · doi:10.1016/j.ijchy.2020.100029 · Cited by 147
Novel liquid chromatography tandem mass spectrometry (LC-MS/MS) methods for measuring steroids
Keevil, B. G. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.05.015 · Cited by 154
Screening for Endocrine Hypertension: An Endocrine Society Scientific Statement
Young, W. F., Calhoun, D. A., Lenders, J. W. M., Stowasser, M., & Textor, S. C. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00054 · Cited by 144
Self-citation
Metadata
- Authors
- Ahmed, A. H., Gordon, R. D., Taylor, P. J., Ward, G., Pimenta, E., & Stowasser, M.
- Affiliations
- The University of Queensland (AU)
- Sullivan Nicolaides Pathology (AU)
- Corresponding author
- Stowasser, Michael
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2011-02
- Volume
- 96
- Issue
- 2
- Pages
- E340-E346
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1988501908
- Cited by
- 96
- References
- 29
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 3 · 2023: 9 · 2022: 6 · 2021: 3 · 2020: 10 · 2019: 7 · 2018: 5 · 2017: 13 · 2016: 5 · 2015: 4 · 2014: 11 · 2013: 7 · 2012: 2
- FWCI
- 3.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- primary aldosteronism, aldosterone-renin ratio, false-positive screening results, sex differences, menstrual cycle, luteal phase, progesterone, plasma renin activity, reference values, hypertension screening
- MeSH terms
- Adult, Aldosterone, Mineralocorticoid Receptor Antagonists, Chromatography, High Pressure Liquid, False Positive Reactions, Female, Follicle Stimulating Hormone, Humans, Hydrocortisone, Hyperaldosteronism, Immunoassay, Male, Menstrual Cycle, Progesterone, Renin, Sex Characteristics, Tandem Mass Spectrometry
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.